Table 1 Baseline characteristics.

From: Predicting adverse events after thoracic endovascular aortic repair for patients with type B aortic dissection

Variables

All patients (n = 172)

the non-AEs group (n = 131)

The AEs group (n = 41)

P

Follow-up time, years

2.8 (1.5–3.8)

3.1 (2.1–4.0)

0.2(0.02–1.0)

 < 0.001

Age(years)

55.5 ± 11.5

55.5 ± 11.1

55.6 ± 13.0

0.968

 Age≥ 74 years, n (%)

9 (5.23%)

3 (2.29%)

6 (14.6%)

0.006

Male, n (%)

134 (77.9%)

100 (76.3%)

34 (82.9%)

0.502

SBP, mmHg

163 ± 29.6

164 ± 30.3

159 ± 27.3

0.295

DBP, mmHg

94.6 ± 18.8

95.2 ± 19.4

92.5 ± 17.1

0.404

HR, time/min

79.7 ± 13.6

79.8 ± 13.8

79.1 ± 13.2

0.760

Sudden chest pain, n (%)

129 (75.0%)

102 (77.9%)

27 (65.9%)

0.179

Myocardial ischemia, n (%)

69 (40.1%)

55 (42.0%)

14 (34.1%)

0.477

Pericardial effusion, n (%)

12 (6.98%)

9 (6.87%)

3 (7.32%)

1.000

Pleural effusion, n (%)

56 (32.6%)

43 (32.8%)

13 (31.7%)

1.000

LEM, n (%)

20 (11.6%)

10 (7.63%)

10 (24.4%)

0.009

Hypertension, n (%)

126 (73.3%)

101 (77.1%)

25 (61.0%)

0.067

History of TAA, n (%)

4 (2.33%)

2 (1.53%)

2 (4.88%)

0.241

Marfan syndrome, n (%)

2 (1.16%)

1 (0.76%)

1 (2.44%)

0.421

TAI, n (%)

6 (3.49%)

5 (3.82%)

1 (2.44%)

1.000

History of cardiac operation, n (%)

4 (2.33%)

2 (1.53%)

2 (4.88%)

0.241

Diabetes, n (%)

7 (4.07%)

6 (4.58%)

1 (2.44%)

1.000

CAD, n (%)

20 (11.6%)

16 (12.2%)

4 (9.76%)

0.786

Stroke, n (%)

18 (10.5%)

12 (9.16%)

6 (14.6%)

0.380

COPD, n (%)

15 (8.72%)

11 (8.40%)

4 (9.76%)

0.757

Cancer, n (%)

5 (2.91%)

3 (2.29%)

2 (4.88%)

0.594

Smoker, n (%)

89 (51.7%)

63 (48.1%)

26 (63.4%)

0.125

Drinker, n (%)

17 (9.88%)

14 (10.7%)

3 (7.32%)

0.765

Hb, g/L

134 ± 21.6

135 ± 20.6

132 ± 24.5

0.541

PLT, × 109/L

180 ± 62.6

181 ± 62.3

176 ± 64.2

0.612

WBC, × 109/L

9.96 ± 3.46

10.0 ± 3.49

9.76 ± 3.42

0.677

NLR, %

7.2 (4.1–12.5)

7.0 (4.0–11.5)

7.9 (5.0–13.8)

0.426

CRP, mg/L

10.0 (10.0–43.5)

10.0 (10.0–43.6)

10.0 (10.0–31.8)

0.899

ALT, U/L

20.0 (13.0–33.8)

19.0 (13.0–34.0)

23.0 (15.5–34.0)

0.353

Scr, μmol/L

65.0 (53.3–88.8)

63.0 (52.0–80.0)

79.0 (61.5–96.5)

0.004

D-dimer, mg/L

2.7 (1.4–5.5)

2.7 (1.5–5.5)

2.7 (1.1–7.0)

0.901

NT-proBNP, pg/mL

219.1 (97.3–485.7)

198.4 (88.6–399.6)

368.0 (111.0–870.1)

0.021

  NT-proBNP> 330 pg/mL, n(%)

59 (34.3%)

37 (28.2%)

22 (53.7%)

0.005

CK, U/L

70.5 (45.0–122.0)

67.0 (44.0–113.0)

87.0 (49.0–162.0)

0.233

  1. Values are expressed as mean ± SD or n (%), SD, standard deviation.
  2. Significant values are in bold.
  3. SBP, systolic blood pressure; DBP, diastolic blood pressure; HR: heart rate; LEM, lower extremity malperfusion; TAA, thoracic aortic aneurysm; TAI, traumatic aortic injury; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; Hb, hemoglobin; PLT, platelet; WBC, white blood cell; NLR, neutrophil-to-lymphocyte ratio; CRP, C-reactive protein; ALT, alanine aminotransferase; Scr, serum creatinine; NT-proBNP: N-terminal pro-B-type natriuretic peptide; CK, creatine kinase.
Back to article page